DK154765C - Analogifremgangsmaade til fremstilling af piperazinoner eller physiologisk acceptable syreadditionssalte deraf - Google Patents
Analogifremgangsmaade til fremstilling af piperazinoner eller physiologisk acceptable syreadditionssalte derafInfo
- Publication number
- DK154765C DK154765C DK342382A DK342382A DK154765C DK 154765 C DK154765 C DK 154765C DK 342382 A DK342382 A DK 342382A DK 342382 A DK342382 A DK 342382A DK 154765 C DK154765 C DK 154765C
- Authority
- DK
- Denmark
- Prior art keywords
- addition salts
- acceptable acid
- piperazinon
- analogue
- preparing
- Prior art date
Links
- IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3132882 | 1981-08-20 | ||
| DE19813132882 DE3132882A1 (de) | 1981-08-20 | 1981-08-20 | Neue piperazinone, ihre herstellung und verwendung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK342382A DK342382A (da) | 1983-02-21 |
| DK154765B DK154765B (da) | 1988-12-19 |
| DK154765C true DK154765C (da) | 1989-05-16 |
Family
ID=6139695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK342382A DK154765C (da) | 1981-08-20 | 1982-07-30 | Analogifremgangsmaade til fremstilling af piperazinoner eller physiologisk acceptable syreadditionssalte deraf |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4598079A (da) |
| EP (1) | EP0072932B1 (da) |
| JP (1) | JPS5839673A (da) |
| KR (1) | KR880001622B1 (da) |
| AT (1) | ATE49596T1 (da) |
| AU (1) | AU556064B2 (da) |
| BG (1) | BG40142A3 (da) |
| CA (1) | CA1190227A (da) |
| DD (1) | DD206991A5 (da) |
| DE (2) | DE3132882A1 (da) |
| DK (1) | DK154765C (da) |
| ES (1) | ES8305739A1 (da) |
| FI (1) | FI76325C (da) |
| GR (1) | GR78362B (da) |
| HU (1) | HU190696B (da) |
| IL (1) | IL66566A (da) |
| NO (1) | NO822643L (da) |
| NZ (1) | NZ200761A (da) |
| PH (1) | PH18447A (da) |
| PL (1) | PL139405B1 (da) |
| PT (1) | PT75444B (da) |
| RO (1) | RO85267B (da) |
| ZA (1) | ZA826031B (da) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772705A (en) * | 1985-07-25 | 1988-09-20 | Pennwalt Corporation | Processes for the preparation of trans 1,3,4,6,7,11b-hexahydro-7-aryl-2H-pyrazinol[2,1-a]isoquinolines |
| JPS62198671A (ja) * | 1986-02-25 | 1987-09-02 | Toyo Jozo Co Ltd | １−置換アルキル１，２−ジヒドロ−２−ピラジノン誘導体 |
| DE3817198A1 (de) * | 1988-05-20 | 1989-11-30 | Cassella Ag | Thienyl-piperazinone, ihre herstellung und verwendung |
| US5238938A (en) * | 1989-02-10 | 1993-08-24 | Otsuka Pharmaceutical Co., Ltd. | Indole derivatives |
| WO1990009380A1 (fr) * | 1989-02-10 | 1990-08-23 | Otsuka Pharmaceutical Co., Ltd. | Derives d'indole, leur preparation et medicament les contenant destine a la prevention et au traitement de la nephrite |
| DE3908547A1 (de) * | 1989-03-16 | 1990-09-20 | Cassella Ag | Thienylessigsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung |
| DE3909379A1 (de) * | 1989-03-22 | 1990-09-27 | Cassella Ag | Thienylpiperazine, verfahren zu ihrer herstellung, ihre verwendung sowie diese enthaltende arzneimittel und deren herstellung |
| US5635510A (en) * | 1993-05-06 | 1997-06-03 | Merrell Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines |
| IL111730A (en) * | 1993-11-29 | 1998-12-06 | Fujisawa Pharmaceutical Co | Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5883098A (en) * | 1993-11-29 | 1999-03-16 | Fujisawa Pharmaceutical Co., Ltd. | Piperazine derivatives |
| DE4408530A1 (de) * | 1994-03-14 | 1995-09-28 | Hoechst Ag | Verfahren zur Herstellung von Aminoethylglycin |
| CA2198084C (en) | 1994-08-25 | 2000-03-28 | Timothy P. Burkholder | Novel substituted piperidines useful for the treatment of allergic diseases |
| FI973671A0 (fi) * | 1995-03-15 | 1997-09-12 | Hoechst Marion Roussel Inc | Heterosyklisen substituentin sisältäviä piperatsinonijohdoksia takykiniinireseptoriantagonisteina |
| JP3950170B2 (ja) * | 1995-04-13 | 2007-07-25 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | タキキニン受容体アンタゴニスト活性を有する新規な置換されたピペラジン誘導体 |
| GB9510600D0 (en) * | 1995-05-25 | 1995-07-19 | Fujisawa Pharmaceutical Co | Piperazine derivatives |
| US6211199B1 (en) | 1995-11-17 | 2001-04-03 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| US6194406B1 (en) | 1995-12-20 | 2001-02-27 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease |
| US6423704B2 (en) | 1995-12-20 | 2002-07-23 | Aventis Pharmaceuticals Inc. | Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| US5932571A (en) * | 1996-02-21 | 1999-08-03 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases |
| US5998439A (en) | 1996-02-21 | 1999-12-07 | Hoescht Marion Roussel, Inc. | Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| US5922737A (en) * | 1996-02-21 | 1999-07-13 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases |
| WO1997036591A1 (en) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| SE9603283D0 (sv) * | 1996-09-10 | 1996-09-10 | Astra Ab | New compounds |
| TW472045B (en) * | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
| AR017200A1 (es) | 1997-12-23 | 2001-08-22 | Astrazeneca Ab | Compuestos inhibidores de la proteina cinasa c, sales farmaceuticamente aceptables de los mismos, formulaciones farmaceuitcas que los comprenden, usode las mismas y proceso para la sintesis de dichos compuestos |
| SE9800835D0 (sv) | 1998-03-13 | 1998-03-13 | Astra Ab | New Compounds |
| US6492406B1 (en) | 1999-05-21 | 2002-12-10 | Astrazeneca Ab | Pharmaceutically active compounds |
| US6346625B1 (en) | 1999-06-23 | 2002-02-12 | Astrazeneca Ab | Protein kinase inhibitors |
| IN190478B (da) * | 2000-11-07 | 2003-08-02 | Sun Pharmaceutical Ind Ltd | |
| WO2003024401A2 (en) * | 2001-09-18 | 2003-03-27 | Bristol-Myers Squibb Company | Piperizinones as modulators of chemokine receptor activity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1197089B (de) * | 1962-01-25 | 1965-07-22 | Richardson Merrell Inc | Verfahren zur Herstellung von 2-Oxo-1, 2, 5, 6-tetrahydropyrazinen |
| US3390139A (en) * | 1964-03-04 | 1966-03-11 | Rohm & Haas | Nu-vinyl-2-piperazinones |
| US3935214A (en) * | 1968-07-26 | 1976-01-27 | Donau-Pharmazie Gesellschaft M.B.H. | 2-or 3 keto-3-or-2-phenyl-1,4-disubstituted piperazines |
| DE2438619A1 (de) * | 1974-08-12 | 1976-02-26 | Knoll Ag | Verfahren zur herstellung von substituierten 2-ketopiperazin-derivaten |
| AT356122B (de) * | 1978-10-17 | 1980-04-10 | Yoshitomi Pharmaceutical | Verfahren zur herstellung von neuen pyridazinonderivaten und ihren salzen mit saeuren |
-
1981
- 1981-08-20 DE DE19813132882 patent/DE3132882A1/de not_active Withdrawn
-
1982
- 1982-05-27 NZ NZ200761A patent/NZ200761A/en unknown
- 1982-06-21 CA CA000405637A patent/CA1190227A/en not_active Expired
- 1982-07-27 AT AT82106766T patent/ATE49596T1/de active
- 1982-07-27 DE DE8282106766T patent/DE3280088D1/de not_active Expired - Lifetime
- 1982-07-27 EP EP82106766A patent/EP0072932B1/de not_active Expired - Lifetime
- 1982-07-30 DK DK342382A patent/DK154765C/da not_active IP Right Cessation
- 1982-08-02 FI FI822698A patent/FI76325C/fi not_active IP Right Cessation
- 1982-08-02 NO NO822643A patent/NO822643L/no unknown
- 1982-08-05 DD DD82242277A patent/DD206991A5/de unknown
- 1982-08-18 PL PL1982237952A patent/PL139405B1/pl unknown
- 1982-08-18 IL IL66566A patent/IL66566A/xx unknown
- 1982-08-18 GR GR69058A patent/GR78362B/el unknown
- 1982-08-18 BG BG057771A patent/BG40142A3/xx unknown
- 1982-08-19 JP JP57142738A patent/JPS5839673A/ja active Pending
- 1982-08-19 PT PT75444A patent/PT75444B/pt unknown
- 1982-08-19 PH PH27754A patent/PH18447A/en unknown
- 1982-08-19 ES ES515120A patent/ES8305739A1/es not_active Expired
- 1982-08-19 AU AU87422/82A patent/AU556064B2/en not_active Ceased
- 1982-08-19 RO RO108482A patent/RO85267B/ro unknown
- 1982-08-19 HU HU822696A patent/HU190696B/hu unknown
- 1982-08-19 ZA ZA826031A patent/ZA826031B/xx unknown
- 1982-08-19 KR KR8203731A patent/KR880001622B1/ko not_active Expired
-
1984
- 1984-05-15 US US06/610,921 patent/US4598079A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK154765C (da) | Analogifremgangsmaade til fremstilling af piperazinoner eller physiologisk acceptable syreadditionssalte deraf | |
| DE3865869D1 (de) | Kohlenstoffhaltiges sorbentmittel zur trennung von pyrogenen und dessen verwendung zur erzeugung von reinem wasser. | |
| NO971568L (no) | Analoger av keratinocyttvekstfaktor | |
| PT77213A (de) | Pasteurisiertes human-fibrinogen (hf) verfahren zu dessen herstellung und dessen verwendung | |
| JPS6468255A (en) | Artificial device for composing thighbone in knee joint | |
| ATE259369T1 (de) | Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen | |
| FI874676L (fi) | Menetelmä anti-HIV:n määrittämiseksi, tarvikkeet sitä varten ja niiden käyttö tässä menetelmässä | |
| GB2134392B (en) | Improvements in four bar linkages for knee joints of artificial legs | |
| IE810276L (en) | Phenylpiperazine derivatives of oxadiazoles | |
| PT85830A (de) | Neue monoklonale antikorper gegen ifn-omega verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega | |
| NO923333L (no) | Vasoaktive vasotocinderivater | |
| ATE2327T1 (de) | Pyrazincarboxamide, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ES2045036T3 (es) | Procedimiento para la obtencion de n-etilpiperazina. | |
| AU6826487A (en) | Surgery for strengthening tendon in horses leg | |
| IL97110A0 (en) | Benzylphosphonic acid derivatives,compositions containing them and their use in treating viral diseases | |
| BG97851A (en) | Hard dosed forms of almocalante and method for obtaining them | |
| SE8400118D0 (sv) | Substituted carboxy-thiazolo(3,2-a)pyrimidine derivatives and process for their preparation | |
| DE3785953D1 (de) | Bakterientoetende gemische. | |
| JPS558712A (en) | Knee joint in framework artificial leg | |
| AT389114B (de) | 7-acyloxy-6-aminoacyloxypolyoxylabdane und verfahren zu ihrer herstellung | |
| ES2139524B1 (es) | Masa para modelar para niños y adultos. | |
| ATE18994T1 (de) | Neue pharmazeutische zusammensetzung. | |
| ATA58982A (de) | Verfahren zur herstellung neuer pyrido-(1,2-a) pyrimidin-derivate, von deren pharmazeutisch akzeptablen salzen sowie deren solvaten, stereoisomeren und tautomeren | |
| ATE75488T1 (de) | Analoge interferon-polypeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATA16784A (de) | Verwendung von 3-substituierten tetrahydropyrrolo(1,2-a)pyrimidin-derivaten sowie von deren saeureadditions- und quaternaeren salzen zur herstellung von pharmazeutischen praeparaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |